BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center For Technology Licensing - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Center For Technology Licensing
X-ORIGINAL-URL:https://ctl.cornell.edu
X-WR-CALDESC:Events for Center For Technology Licensing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250926T113000
DTEND;TZID=America/New_York:20250926T130000
DTSTAMP:20260529T225936
CREATED:20250919T213958Z
LAST-MODIFIED:20250919T213958Z
UID:10000573-1758886200-1758891600@ctl.cornell.edu
SUMMARY:Advancing Women's Health
DESCRIPTION:Join this special women’s health webinar spotlighting exciting new research at Weill Cornell Medicine. Dr. Zhen Zhao\, Professor of Clinical Pathology and Laboratory Medicine\, will present her idea for an AI-based clinical decision support tool for predicting the risk of pre-eclampsia. \nFollowing this scientific presentation\, we’ll be sitting down with the authors of “Unlocking Investment for Women’s Health”\, Dr. Misti Ushio\, Managing Partner\, Digitalis Ventures\, and Ipsita Smolinski\, Founder & General Partner\, Capitol Street\, to explore today’s funding landscape and discuss how investors\, government\, industry and advocacy groups can work together to accelerate innovations in women’s health. \nDon’t miss this opportunity to hear fresh perspectives and novel solutions that can have a significant impact on the women’s health sector in the near term. \nRegister here.
URL:https://ctl.cornell.edu/event/advancing-womens-health
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2025/09/CMTtKtJzFfEFjNNhiA90lnAX_RWKDbfgKsp0cWwozNs-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240315T180000
DTEND;TZID=America/New_York:20240315T200000
DTSTAMP:20260529T225936
CREATED:20240304T144636Z
LAST-MODIFIED:20240304T144636Z
UID:10000492-1710525600-1710532800@ctl.cornell.edu
SUMMARY:Tri-Institutional Entrepreneurship Organizations: Helping to Launch Your Science to the Public
DESCRIPTION:Are you a graduate student or postdoc from Rockefeller University\, Memorial Sloan Kettering\, or Weill Cornell Medicine who is interested in bringing your science to the public? Join us to meet the leaders helping to propel life science entrepreneurs ahead! \n​Hosted by the startup venture group\, Bioventure eLab\, Life Sciences Technology and Innovation Fellows\, Center for Technology and Licensing\, and Postdoc Runway Startup Program\, we invite you to learn about the incredible organizations that will help you along every stage of your entrepreneurial path. \n​We will begin with an introduction from each organization followed by a Q&A from the audience. Following the Q&A\, a fair-style approach in which each organization will be seated at a table to discuss more about the programs they offer with the audience will occur. \n​Speakers representing each organization include: \n\nBioventure eLab – Loren Busby\n​Life Sciences Technology and Innovation Fellows – Gregory Ray\n​Center for Technology and Licensing – Lynda Inseque\n​Postdoc Runway Startup Program – Tomer Joshua\n\n​This is an incredible opportunity to learn about how to develop your science into a product that can directly impact the lives of others! \n​Food and non-alcoholic beverages will be provided! Register now.
URL:https://ctl.cornell.edu/event/tri-institutional-entrepreneurship-organizations-helping-to-launch-your-science-to-the-public
CATEGORIES:CTL Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2024/03/Events-page-image-size-700x500px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240228T100000
DTEND;TZID=America/New_York:20240228T170000
DTSTAMP:20260529T225936
CREATED:20240205T142639Z
LAST-MODIFIED:20240205T142639Z
UID:10000482-1709114400-1709139600@ctl.cornell.edu
SUMMARY:Annual Weill Cornell Medicine Startup Symposium & InvestConnect Conference
DESCRIPTION:You are invited to join the annual Weill Cornell Medicine Startup Symposium & InvestConnect Conference on Wednesday\, February 28\, 10:00 a.m.- 5:00 p.m. ET.  This full-day program is an opportunity to celebrate innovation &  entrepreneurship and engage with like-minded founders\, investors and industry representatives. Featured presentations will include: \n– An interview with Bruce R.\, Weill Cornell Medicine Board of Fellows member\, and Adam Bonislawski\, Editor with GenomeWeb\, co-authors of Early Detection: Catching Cancer When It’s Curable. In addition to being a prolific NYC real estate developer and philanthropist\, Mr. Ratner is the founder of the Michael D. Ratner Center for Early Detection of Cancer\, a non-profit established in the name of his older brother who passed away from metastatic cancer. He also sits on the boards of Memorial Sloan Kettering Cancer Center and the Cold Spring Harbor Laboratory. This lunchtime interview will be moderated by John Leonard\, M.D.\, Senior Associate Dean for Innovation and Initiatives. \n– A discussion on therapeutics with Barry Kappel\, Ph.D. ‘06\, Founder\, President & CEO of Sapience Therapeutics\, Inc. \n– An update on a novel neurotech startup being formed by Nicholas D. Schiff\, M.D. ’92\, the Jerald B. Katz Professor of Neurology and Neuroscience and Professor of Neuroscience at the Brain and Mind Research Institute. \n– A company update from Bernard Peperstraete\, MD\, MBA\, Co-Founder\, President & CEO of Acuamark Diagnostics\, Inc.\, a liquid biopsy company that is optimizing qPCR and dPCR for early detection of cancer. \nThe conference takes place on-campus at Belfer Research Building\, 413 E 69th St and will feature a startup expo and networking reception. Don’t miss out on an opportunity to meet WCM innovators and make impactful industry connections! \nhttps://2024startupsymposiumwcm.splashthat.com/
URL:https://ctl.cornell.edu/event/annual-weill-cornell-medicine-startup-symposium-investconnect-conference
CATEGORIES:CTL Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2024/02/Screenshot-2024-02-05-at-9.23.35-AM.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231206T180000
DTEND;TZID=America/New_York:20231206T210000
DTSTAMP:20260529T225936
CREATED:20231121T040134Z
LAST-MODIFIED:20231121T040134Z
UID:10000469-1701885600-1701896400@ctl.cornell.edu
SUMMARY:Accelerating BioVenture Innovation Final Pitch Event
DESCRIPTION:Join us on campus as the finalist teams from the 2023 Accelerating BioVenture Innovation course pitch their technologies to a panel of early-stage investors. The teams have spent 15 weeks learning material from a variety of industry professionals with rigorous coursework to help them prepare and deliver their pitches. \nFollowing the pitches there will be a networking reception with investors\, ecosystem partners\, and industry representatives who served as mentors and lecturers throughout our program. Come celebrate the winning teams with hors d’oeuvres and cocktails! \nRegister here.
URL:https://ctl.cornell.edu/event/accelerating-bioventure-innovation-final-pitch-event
CATEGORIES:Partner Events
ATTACH;FMTTYPE=image/jpeg:https://ctl.cornell.edu/wp-content/uploads/2023/11/https___cdn.evbuc_.com_images_641719069_1043578448253_1_original.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230829T173000
DTEND;TZID=America/New_York:20230829T203000
DTSTAMP:20260529T225936
CREATED:20230812T225526Z
LAST-MODIFIED:20230812T225632Z
UID:10000441-1693330200-1693341000@ctl.cornell.edu
SUMMARY:Accelerating BioVenture Innovation Kick-Off
DESCRIPTION:We formally invite you to join Weill Cornell Medicine and the greater NYC life science startup community for the kick-off of our Accelerating BioVenture Innovation accelerator with special guest – Erandi De Silva\, PhD\, Co-Founder & Senior Vice President of Product Development at Forge Biologics!  Dr. De Silva was selected by Fierce Pharma as one of its 2022 Fiercest Women in Life Sciences. We are excited to have her on campus to share her personal story and startup journey. \nThe event is scheduled for Tuesday\, August 29\, 5:30-8:30pm. It will take place in-person at Uris Auditorium\, 1300 York Avenue @ 69th Street\, and will be followed by a networking reception with cocktails in Griffis Faculty Lounge (same location). This is a great opportunity to meet like-minded faculty\, trainees and clinicians interested in translational science and medicine.  \nRegister HERE \n\nAbout Forge Biologics \nForge Biologics is a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company. Forge’s mission is to enable access to life-changing gene therapies and help bring them from idea to reality. Forge’s 200\,000 square foot facility utilizes 20 cGMP suites in Columbus\, Ohio\, the Hearth\, to serve as its headquarters. The Hearth is a custom-designed cGMP facility dedicated to AAV manufacturing and hosts scalable\, end-to-end manufacturing services. Offerings include process and analytical development\, plasmid DNA manufacturing\, viral vector manufacturing\, final fill\, as well as regulatory consulting support to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. Investors include Drive Capital\, Perceptive Xontogeny Venture Fund\, RA Capital Management\, Surveyor Capital (a Citadel company)\, Octagon Capital\, Marshall Wace\, and Aisling Capital. By taking a patients-first approach\, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most. To learn more\, visit www.forgebiologics.com. \n About Accelerating BioVenture Innovation  \nABI is a training program for life science postdocs/trainees\, PhD students\, and medical school students. The 15-week program builds teams around patented technologies from Weill Cornell Medicine\, Memorial Sloan Kettering Cancer Center and Rockefeller University. Teams develop business plans in the form of an investor pitch around these technologies. The teams are matched with MBA students and biotech industry professionals to broaden their business acumen and promote collaboration. Weekly lectures cover various startup fundamentals. At the end of the course\, the teams compete in a final pitch event with institutional VCs and angel investors as judges. If you are interested in participating in this Fall course\, please register here.
URL:https://ctl.cornell.edu/event/accelerating-bioventure-innovation-kick-off
LOCATION:Uris Auditorium\, 1300 York Avenue\, New York\, 10065\, United States
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/08/Events-page-image-size-700x500px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230615T120000
DTEND;TZID=America/New_York:20230615T130000
DTSTAMP:20260529T225936
CREATED:20230613T043428Z
LAST-MODIFIED:20230613T043624Z
UID:10000412-1686830400-1686834000@ctl.cornell.edu
SUMMARY:Top Ten Regulatory Pitfalls for Life Science Startups to Avoid (Virtual Webinar)
DESCRIPTION:Top Ten Regulatory Pitfalls for Life Science Startups to Avoid \nIn what is clearly a challenging time for many businesses\, keeping pace with new and changing federal\, state\, and international regulations is one of many factors that is critical to a startup’s success. The Moses & Singer team has compiled a list of the top 10 regulatory pitfalls that life science companies should try to avoid. \nJoin us for this discussion and learn how to manage these risks as you develop your medical and biotech innovations. \nRegister for the event here.
URL:https://ctl.cornell.edu/event/bioventure-elab-virtual-webinar-ten-pitfalls-for-life-science-startups-to-avoid
LOCATION:TBD
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=image/png:https://ctl.cornell.edu/wp-content/uploads/2023/06/Top-Ten-Regulatory-Pitfalls-for-startups-to-avoid-700-×-500-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220407T093000
DTEND;TZID=UTC:20220407T103000
DTSTAMP:20260529T225936
CREATED:20220322T224812Z
LAST-MODIFIED:20220322T224812Z
UID:10000264-1649323800-1649327400@ctl.cornell.edu
SUMMARY:Alexandria in NYC: Overview + Breakfast
DESCRIPTION:Weill Cornell Medicine Enterprise Innovation is excited to welcome to campus representatives from Alexandria Real Estate Equities: \nJenna Foger – SVP\, Science & Technology \nWhitney Snider\, MD MBA – VP\, Science & Technology \nCat Donaldson\, PhD MBA – Executive Director\, Alexandria LaunchLabs at ACLS NYC \nMichael Norsen\, MBA – Head of Alexandria LaunchLabs at Columbia NYC \n  \nAlexandria has a strong track record of investing and delivering on building life science-centric real estate clusters in New York City for more than a decade. Over breakfast\, the Alexandria team will introduce Alexandria’s mission and provide an overview of the types of support available to academic researchers and companies in the New York City life sciences ecosystem. \nRegister here for the in-person event. \n  \nFollowing the presentation\, Alexandria representatives will be holding office hours to give you the opportunity to meet with the team one on one and garner informal feedback on your company creation ideas and activities. Sign-up here to reserve your slot! \n  \nNote: All attendees must be fully vaccinated and boosted against SARS-CoV-2 to attend the in-person event!
URL:https://ctl.cornell.edu/event/alexandria-in-nyc-overview-breakfast
LOCATION:Bioventure eLab\, 1157 York Avenue\, New York\, NY\, NY\, 10065\, United States
CATEGORIES:Cornell Community Events
ATTACH;FMTTYPE=:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20220224T100000
DTEND;TZID=UTC:20220224T170000
DTSTAMP:20260529T225936
CREATED:20220222T064518Z
LAST-MODIFIED:20220222T064518Z
UID:10000255-1645696800-1645722000@ctl.cornell.edu
SUMMARY:2022 Startup Symposium & InvestConnect Conference
DESCRIPTION:Agenda \n10:00 AM – 10:15 AM          Welcoming Remarks \n10:15 AM – 11:15 AM          Building a Team Panel \n11:30 AM – 12:30 PM          Keynote Speaker Stanley Lapidus \n12:30 PM – 12:45 PM          Announcement of the Resnick Prize Winner \n12:45 PM – 01:00 PM          Break \n01:00 PM – 04:00 PM          Investor Partnering (InvestConnect) (by invitation only) \n  \nKeynote Speaker: Stanley Lapidus \nStan Lapidus is an inventor and entrepreneur who currently serves on a number of healthcare and medical technology boards. He’s been founding CEO of three medical diagnostics companies. \n  \nPanel: Building a Startup Team\nLaunching Companies Out of Academia
URL:https://ctl.cornell.edu/event/2022-startup-symposium-investconnect-conference
CATEGORIES:Cornell Community Events,Partner Events
ATTACH;FMTTYPE=:
END:VEVENT
END:VCALENDAR